What Is the Difference Between Prednisone and Prednisolone?

Prednisone and prednisolone are so closely related that, in most people, they function as the same drug. Prednisone is inactive on its own; after you swallow it, your liver converts it into prednisolone, the form that actually binds to glucocorticoid receptors and suppresses inflammation. In a healthy liver, roughly 82% of prednisone is converted to prednisolone during that first pass through the organ. The distinction between the two matters far less than most patients assume, but there are specific clinical situations where choosing one over the other genuinely changes outcomes.

How Prednisone Becomes Prednisolone

Prednisone is what pharmacologists call a prodrug. It has no meaningful anti-inflammatory activity by itself. When it reaches the liver, an enzyme called 11-beta-hydroxysteroid dehydrogenase type 1 (usually abbreviated 11β-HSD1) reduces a ketone group at the 11-position of the steroid ring, converting prednisone into prednisolone. This happens quickly, often within minutes of absorption.

The conversion also runs in reverse to a small degree. When you take prednisolone, about 17-18% of it gets oxidized back to prednisone. So regardless of which pill you start with, both compounds circulate in your blood; the balance just shifts depending on which one you swallowed.

The interconversion is what makes these drugs bioequivalent in healthy people. A study of healthy subjects found that whether they took 5 mg of prednisone or an equivalent dose of prednisolone, the key pharmacokinetic measures fell within the standard bioequivalence window, regardless of whether participants had eaten or fasted. Food did delay peak blood levels by about half an hour, but it did not change how much drug ultimately reached the bloodstream.

Why Liver Disease Changes the Equation

The single clearest reason to pick prednisolone over prednisone is significant liver impairment. Because prednisone depends on the liver to become active, a liver that cannot do its job leaves more prednisone unconverted and less active prednisolone circulating. Research in patients with liver cirrhosis demonstrated this starkly: among those with severely impaired liver function, blood levels of prednisolone after an oral dose of prednisone were only about 53% of those seen in patients with mild impairment. Meanwhile, unconverted prednisone levels were 74% higher in the severe group, confirming the bottleneck was in the liver’s conversion step, not in absorption.

⁴

When the same patients received prednisolone directly, bypassing the need for hepatic conversion, their blood levels were independent of how well the liver was functioning. This finding is what drives the clinical rule of thumb: if someone has cirrhosis, autoimmune hepatitis, or another condition that substantially compromises liver enzyme capacity, prescribing prednisolone rather than prednisone avoids the uncertainty around conversion. The drug arrives in the bloodstream already active, and the liver’s role is limited to clearing it afterward.

⁵

For mild liver disease, the distinction is less urgent. The conversion enzyme still works, just less efficiently. Many clinicians still default to prednisolone out of caution, but the pharmacokinetic gap narrows considerably when liver function is only moderately reduced.

Kidney Disease and Dialysis

Kidney failure does not impair the prednisone-to-prednisolone conversion the way liver failure does, because the conversion happens in the liver, not the kidneys. What kidney disease can change is how much prednisolone floats around unbound in the blood. Patients with renal failure have been shown to have increased unbound concentrations of prednisolone, which could intensify both the drug’s effects and its side effects at any given dose.

⁶

As for dialysis, a study of six patients with end-stage renal disease found that prednisolone’s behavior in the blood did not change during hemodialysis or peritoneal dialysis compared to dialysis-free days. The drug is not significantly removed by either type of dialysis, so no supplemental dosing is needed after a session.

⁷

The practical takeaway for kidney patients is that either prednisone or prednisolone can work, but clinicians should be aware that the free (active) fraction of prednisolone may be higher than expected, sometimes requiring dose adjustments.

Inflammatory Bowel Disease

You might assume that diseases of the gut would interfere with absorption of an oral steroid. For inflammatory bowel disease, specifically Crohn’s disease and ulcerative colitis, the evidence is reassuring on the conversion front. A study of patients with active inflammatory bowel disease found that prednisone absorption and its conversion to prednisolone were complete even during active disease flares.

⁸

However, that does not mean prednisolone levels are identical in every IBD patient. Other research has noted that some patients with Crohn’s disease have decreased concentrations of prednisolone, possibly related to altered protein binding or faster clearance during active inflammation.

⁹

So while IBD does not block the conversion from prednisone to prednisolone, it can change how much active drug is available at any given time. In practice, gastroenterologists often prescribe either drug for IBD patients whose liver function is normal, adjusting the dose based on clinical response rather than switching between the two.

What Makes Prednisolone Preferred in Children

In pediatrics, the choice often comes down to something surprisingly mundane: taste. Young children frequently need liquid formulations, and the flavor of a steroid syrup can be the difference between a child swallowing their medicine and spitting it across the room. A blinded taste comparison of liquid prednisone, prednisolone, and dexamethasone found that prednisolone scored significantly better than prednisone in texture, taste, and aftertaste. The difference was meaningful enough that children were more likely to tolerate the prednisolone preparation.

¹⁰

Beyond taste, prednisolone has the advantage of not requiring hepatic conversion, which is reassuring in very young infants whose liver enzyme systems are still maturing. Although healthy children convert prednisone just fine, clinicians tend to default to prednisolone for pediatric prescriptions because the liquid formulation is better tolerated and the pharmacology is more straightforward. In many countries, prednisolone liquid is the standard of care for pediatric asthma exacerbations and croup for this combination of practical and pharmacological reasons.

Protein Binding and the Free Drug Fraction

Both prednisone and prednisolone bind to proteins in the blood, primarily corticosteroid-binding globulin (CBG) and albumin. Only the unbound fraction of the drug is pharmacologically active. Here, the two drugs diverge slightly. At higher concentrations, the unbound fraction of prednisone levels off at about 29%, while the unbound fraction of prednisolone plateaus at about 15%.

¹¹

This means that prednisolone is more tightly protein-bound than prednisone at equivalent concentrations. In practical terms, anything that lowers albumin or CBG levels (liver disease, nephrotic syndrome, old age, critical illness) pushes a larger fraction of prednisolone into the free, active form. Conversely, conditions that raise CBG levels, such as estrogen-containing oral contraceptives, increase total prednisolone in the blood but leave the free fraction relatively stable.

¹²

This binding difference is mostly invisible in standard prescribing. But it becomes clinically relevant when you are dealing with patients who have very low protein levels, because they will have more free prednisolone per dose than expected. It is one reason why patients who are malnourished, critically ill, or have advanced liver disease sometimes seem to get exaggerated steroid side effects.

Other Factors That Shift Prednisolone Levels

The list of variables that can raise or lower prednisolone concentrations is longer than most prescribers realize. A comprehensive pharmacokinetic review identified several patient groups with notably altered prednisolone exposure:

Higher unbound levels: Patients with liver failure, renal failure, or a kidney transplant; adults over 65; women taking estrogen-containing oral contraceptives; and patients taking ketoconazole.
Lower concentrations: People with hyperthyroidism, some patients with Crohn’s disease, patients taking drugs that induce liver enzymes (like rifampin or phenytoin), and patients receiving certain intravenous or enteric-coated formulations of prednisolone.

¹³

The oral-contraceptive effect deserves a moment’s attention because it frequently causes confusion. Estrogen raises CBG levels, which raises total prednisolone in blood tests. But the free (active) fraction stays roughly the same. A clinician who sees a high total prednisolone level and assumes the patient is over-medicated might reflexively lower the dose, when in reality the extra drug is just protein-bound and inactive. This is a common source of unnecessary dose adjustments.

Enzyme-inducing drugs, on the other hand, cause a real reduction in prednisolone exposure by speeding up its breakdown in the liver. If you are taking rifampin for tuberculosis and also need corticosteroid therapy, your doctor may need to increase the prednisone or prednisolone dose to maintain the same anti-inflammatory effect.

Do They Differ in Effectiveness or Side Effects?

Given that prednisone is simply a delivery vehicle for prednisolone, you would expect the two drugs to perform identically in clinical trials, and that is essentially what the evidence shows. A comparative study of 65 rheumatoid arthritis patients treated with various corticosteroids, including prednisone and prednisolone, found comparable anti-inflammatory benefit across all the compounds tested. No single preparation showed a consistently superior therapeutic advantage.

¹⁴

Side effects are dose- and duration-dependent for both, and there is no evidence that one causes more weight gain, bone loss, or blood-sugar elevation than the other at equivalent doses. The side-effect profile is driven by the active molecule, prednisolone, and since both drugs deliver prednisolone to the same receptors, the adverse effects track together. The study authors noted that the practical factors influencing choice are effectiveness, the specific pattern of side effects, ease of administration, and cost.

¹⁵

Cost can actually be a deciding factor. In the United States, generic prednisone tablets tend to be slightly cheaper and more widely stocked than prednisolone tablets. In the UK and Australia, prednisolone is the default prescription, and prednisone is less commonly dispensed. The geographical prescribing pattern is mostly a historical accident of market availability rather than a pharmacological preference.

Suppressing Your Body’s Own Cortisol

Both prednisone and prednisolone suppress the hypothalamic-pituitary-adrenal (HPA) axis, the hormonal loop that controls your body’s production of cortisol. The suppression is a consequence of prednisolone acting on the same receptors that natural cortisol occupies. When exogenous steroid floods the system, the brain’s signaling cascade slows down and the adrenal glands shrink from disuse.

A study of healthy men given prednisone at 25 mg twice daily for five days showed that two days after stopping, their cortisol response to stress was significantly blunted. Five days after stopping, the response to low blood sugar had bounced back to near-normal, but the adrenal glands themselves were still sluggish, taking longer to recover than the pituitary signaling that drives them.

¹⁶

This recovery pattern matters for anyone tapering off either drug. Because prednisone and prednisolone produce the same active compound, the tapering strategy is the same regardless of which one you have been taking. The goal is to gradually reduce the dose so the adrenal glands have time to resume cortisol production without leaving you in a state of adrenal insufficiency.

Prednisolone Relative to Other Steroids

When people compare prednisone and prednisolone, they are really comparing prednisolone to itself under different packaging. A more meaningful comparison is prednisolone against other synthetic glucocorticoids. In terms of potency, prednisolone is roughly four times stronger than hydrocortisone (the synthetic version of natural cortisol) on a milligram-for-milligram basis. It is slightly less potent than methylprednisolone and considerably less potent than dexamethasone, which is about six to seven times stronger than prednisolone per milligram.

¹⁷

These potency differences matter when switching between steroids. If a patient has been on 20 mg of prednisolone and needs to transition to dexamethasone, a straight milligram-for-milligram swap would massively overshoot the intended dose. Dose-equivalence tables exist for this purpose, and clinicians consult them routinely during transitions. The important thing to remember is that prednisone and prednisolone are on the same line of those tables, at a one-to-one ratio, because they deliver the same active drug.

Veterinary Use and Species Differences

The prednisone-versus-prednisolone question comes up frequently among pet owners, particularly cat and dog owners. Dogs handle the conversion well. A pharmacokinetic study showed that oral prednisone was rapidly converted to prednisolone in dogs within 30 minutes, with plasma prednisolone levels reaching roughly six times the levels of unconverted prednisone. The conversion was consistent across different dose sizes, indicating that the enzyme does not get overwhelmed even at higher doses.

¹⁸

Cats are a different story. Veterinarians have long observed that cats convert prednisone to prednisolone less efficiently than dogs or humans, which is why prednisolone is almost universally preferred over prednisone in feline medicine. If your vet prescribed prednisolone specifically for your cat, it is not interchangeable with prednisone the way it might be for you or your dog.

How Prednisone and Prednisolone Are Manufactured

Both drugs owe their existence to microbial chemistry. In the 1950s, researchers discovered that certain bacteria could introduce a double bond into the steroid ring of cortisone and hydrocortisone, producing prednisone and prednisolone respectively. This tiny structural change, a single dehydrogenation at the 1-2 position, dramatically boosts anti-inflammatory potency while reducing some of the mineralocorticoid effects (salt and water retention) that made cortisone problematic at higher doses. Modern pharmaceutical production still relies on microbial biotransformation. Bacteria from the Rhodococcus genus, for example, can catalyze this conversion, yielding prednisone from cortisone and prednisolone from hydrocortisone.

¹⁹

The chemical relationship between cortisone, hydrocortisone, prednisone, and prednisolone forms a tidy two-by-two grid. Cortisone and prednisone are both 11-keto (inactive) forms that need hepatic reduction to become their 11-hydroxy (active) partners: hydrocortisone and prednisolone. What prednisone and prednisolone share, and what cortisone and hydrocortisone lack, is that extra double bond, which is what makes them four to five times more potent as anti-inflammatory agents. Understanding this grid helps explain why prednisone is a prodrug, why hydrocortisone is active on its own, and why prednisolone is both the product of liver metabolism and a standalone drug in its own right.